XiaoMi-AI文件搜索系统
World File Search Systemlocally
课程标题：环境保护
课程目标：课程“环境保护”的课程旨在： - 加深学生关于当代生态危机的原因的理论知识 - 所有学生提供的机会，有机会获得知识，技能，技能，理解，价值观，价值观和态度，以保护和改善生活环境，使他们在实践中应用于人类的生态学（乌尔巴斯的本来的原则），这是乌尔巴斯的原则（纽约市的原则），关于生物多样性，气候变化等国际公约。-create new models of individual behavior towards the environment, not to attack it and to take an active part in solving environmental problems at the local, regional and wider level ("think globally, act locally") Learning Outcomes: -Collects and processes relevant scientific data from various sources on current environmental problems at the local and global level -explains the human-environment relationship (rural, urban, industrial), enumerates the causes of the环境危机并采取环境保护措施。
VA Hudson Valley Health Carey System Momelotinib（ojjaara）中的骨髓纤维化 proprotein转化酶枯草蛋白/KEXIN 9型（PCSK9抑制剂）（Alirocumab偏爱，evolocumab-non-preferred）的标准，用于2024年6月6月 Zilucoplan（Zilbrysq）广泛性肌无力的Gravis ... 白内障提取和人工晶状体植入物 rimegepant（NURTEC）用于情节性偏头痛预防标准，用于2024年8月 Glecaprevir / pibrentasvir（Mavyret）使用标准，用于2024年6月6月更新< / div < / div> 提交 呼吸 VA波特兰医疗保健系统药房居住... 2023年度报告 旧金山VA医疗保健系统 Momelotinib（ojjaara）在2024年1月使用的骨髓纤维化标准 临床服务办公室2023年度报告 心理学实习培训计划 路易斯维尔Robley Rex VAMC
About VA HVHCS (Visit our facility's website at: http://www.hudsonvalley.va.gov/ ) The VA Hudson Valley Health Care System (VA HVHCS) was created in 1996 when the Castle Point VAMC and the Franklin Delano Roosevelt VA Hospital joined in the first locally initiated integration of its kind in the VA sys- tem.va hvhcs为纽约市以北的哈德逊河沿线提供了一个地区。由两个主要仪式，七个基于社区的门诊诊所（CBOC）和三家移动诊所组成，VA HVHCS致力于提供广泛的服务，包括医疗，精神病学和扩展护理。FDR和Castle Point校园是通用医学和手术教学医院。VA HVHCS在药房，牙科，验光和心理学中的居住计划。它还接待了来自各种盟国卫生专业的学生。
Lewisham Medicines优化团队新闻
- 是否针对医学诊断的适应症（即缺乏症）（<25nmol/l或<10mcg/l）规定了维生素D？- 高剂量维生素D是否以治疗治疗期限以外的处方维生素D缺乏症？- 纠正剂量治疗后，应鼓励患者购买维护剂量OTC（Valupak D3 1,000单位（0.01英镑/片剂） - 患者是否有资格通过理事会的维生素D方案获得维生素D？- Where clinically indicated + patient is not eligible for Council's vitamin D scheme + exempt from NHSE self-care directive ,vitamin D may be prescribed by brand in line with local guidance - There are no colecalciferol 2,000 unit preparations recommended in the local guidance, can this be changed to a locally recommended colecalciferol preparation (Stexerol-D3 1,000 unit tablets)?- 目前在所有患者中是否安全开处方？
肾脏健康中的肾脏健康范围更广泛的疾病议程
鉴于与肾脏疾病相关的广泛危险因素，需要取得所有可持续发展目标（SDG）的进展才能实现更好的肾脏健康并提高获得质量和公平的肾脏护理2。然而，到目前为止，进展还不够3）。SDG 3的目标3.4旨在将非传染性疾病（NCD）的过早死亡率降低到2030年。To accelerate progress towards SDG target 3.4, the WHO supports domestic capacity to enhance action across different sectors of government and offers countries guidance, through prioritization of a combination of locally appropriate interven- tions, to tackle risk factors and prevent, diagnose and treat NCDs at the primary-care level (Supplementary Fig.1和补充表1）。在2000年至2019年之间，慢性呼吸道疾病，心血管疾病和癌症的年龄标准化死亡率显着降低，但对于糖尿病和糖尿病肾脏疾病，这些疾病的年龄降低了，这些疾病持续增加了4、5。
肿瘤学-分子分析-实体肿瘤-血液学-...
1. 疑似或已证实的转移性结直肠癌，或 2. 晚期或转移性非小细胞肺癌（NSCLC），或 3. III 期或 IV 期皮肤黑色素瘤，或 4. 需要活检的不确定的甲状腺结节，或 5. 未分化甲状腺癌，或 6. 局部复发、晚期和/或转移性乳头状甲状腺癌，或 7. 局部复发、晚期和/或转移性滤泡性甲状腺癌，或 8. 局部复发、晚期和/或转移性赫尔特尔细胞甲状腺癌，或 9. 低级别神经胶质瘤或毛细胞星形细胞瘤，或 10. 可切除或边缘可切除或局部晚期/转移性胰腺癌
Citrix安全私人Acces
• Zero Trust Network Access (ZTNA) to all IT- sanctioned apps • Adaptive Authentication to apply dynamic Multi- Factor-Authentication by classifying devices using Device Posture service (including 3rd party integration of Microsoft Intune or Crowdstrike), user role, geo-location and more • Adaptive Access & Security Controls to provide granular access to applications and apply contextual security controls on browser-based apps to protect sensitive corporate data • Enterprise Browser — A fully managed and locally installed chromium-based browser to access internal Web and SaaS apps, and to securely navigate the web both on managed and BYO devices • Single Sign On for seamless access to browser- based apps • Remote Browser Isolation to navigate the web without risk to corporate environments using a one- time browser • Visibility & Monitoring to provide visibility across all application and user traffic in a单个监视仪表板
Cadth报销建议
One international, double-blind, randomized, phase III study (TOPAZ-1) consisting of previously untreated adult patients with locally advanced or metastatic BTC demonstrated that treatment with durvalumab plus gemcitabine and cisplatin resulted in a statistically significant overall survival (OS) advantage compared to placebo plus gemcitabine and cisplatin (median OS, 12.9 months [95% CI, 11.6 to 14.1个月]与11.3个月[95％CI，10.1至12.5个月]，HR，0.76 [95％CI，0.64至0。91]）。在地标为12-（54.3％对47.1％），18-（34.8％对24.1％）和24.1％）和24个月（23.6％vs. 11.5％）的OS的其他分析支持了Durvalumab Plus Plus Gemcitabine和gemcitabine和cisplatin所证明的生存优势。durvalumab也与无进展生存率的改善有关（[PFS] HR，0.75 [95％CI，0.63至0.89]），并且没有其他严重的安全问题，可管理的毒性概况。TOPAZ-1试验的结果也表明HRQOL没有损害。
TAGRISSO® (osimertinib) tablets, for oral use
adjuvant therapy after tumor resection in adult patients with non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 L858R mutations, as detected by an FDA-approved test (1.1, 2.2) the first-line treatment of adult patients with metastatic NSCLC whose tumors have EGFR exon 19 deletions or exon 21 L858R mutations, as detected by an FDA-approved test. (1.2, 2.2) in combination with pemetrexed and platinum-based chemotherapy, the first-line treatment of adult patients with locally advanced or metastatic NSCLC whose tumors have EGFR exon 19 deletions or exon 21 L858R mutations, as detected by an FDA-approved test. (1.3, 2.2) the treatment of adult patients with metastatic EGFR T790M mutation- positive NSCLC, as detected by an FDA-approved test, whose disease has progressed on or after EGFR TKI therapy. (1.4, 2.2)
特别授权-Pembrolizumab
初始应用 - 仅根据医学肿瘤学家的建议，仅来自医学肿瘤学家或任何相关从业者的非小细胞肺癌一线单药治疗应用。批准有效期为4个月。Prerequisites (tick boxes where appropriate) □ Patient has locally advanced or metastatic, unresectable, non-small cell lung cancer and □ Patient has not had chemotherapy for their disease in the palliative setting and □ Patient has not received prior funded treatment with an immune checkpoint inhibitor for NSCLC and □ For patients with non-squamous histology there is documentation confirming that the disease does not express activating mutations of EGFR or ALK tyrosine kinase unless not possible to ascertain and □ Pembrolizumab to be used as monotherapy and □ There is documentation confirming the disease expresses PD-L1 at a level greater than or equal to 50% as determined by a validated test unless not possible to ascertain or □ There is documentation confirming the disease expresses PD-L1 at a level greater than or equal to 1% as determined by a validated test unless not possible to ascertain and □根据临床医生评估，化学疗法被确定为患者的最大利益
国家康复和恢复的国家种子策略
•扩大农民种植本地适应的本地种子的经济机会。•积极与美洲原住民部落和阿拉斯加原住民村庄互动，以纪念其土著知识，并确保保存具有文化重要性的植物。•增加联邦机构的植物专业知识，以告知所有恢复，康复和开垦项目。•与开发，存储和交付本地适应本地种子的合作伙伴开发区域“种子枢纽”。•增加研究以根据从种子收集到修复的每一步的科学来增强决策。•提高公共教育和对本地适应本地种子在生态恢复中的重要性的认识。